Cited by 91Protein Degradation and InhibitorsUbiquitin and proteasome pathwaysCRISPR and Genetic Engineering

An affinity-directed protein missile system for targeted proteolysis

Open access
Fulcher, Luke J., Macartney, Thomas, Bozatzi, Polyxeni, Hornberger, Annika, Rojas-Fernandez, Alejandro, Sapkota, Gopal P.·2016·Open Biology

Abstract

The von Hippel–Lindau (VHL) protein serves to recruit the hypoxia-inducible factor alpha (HIF1α) protein under normoxia to the CUL2 E3 ubiquitin ligase for its ubiquitylation and degradation through the proteasome. In this report, we modify VHL to engineer an affinity-directed protein missile (AdPROM) system to direct specific endogenous target proteins for proteolysis in mammalian cells. The proteolytic AdPROM construct harbours a cameloid anti-green fluorescence protein (aGFP) nanobody that is fused to VHL for either constitutive or tetracycline-inducible expression. For target proteins, we exploit CRISPR/Cas9 to rapidly generate human kidney HEK293 and U2OS osteosarcoma homozygous knock-in cells harbouring GFP tags at the VPS34 (vacuolar protein sorting 34) and protein associated with SMAD1 (PAWS1, aka FAM83G) loci, respectively. Using these cells, we demonstrate that the expression of the VHL-aGFP AdPROM system results in near-complete degradation of the endogenous GFP-VPS34 and PAWS1-GFP proteins through the proteasome. Additionally, we show that Tet-inducible destruction of GFP-VPS34 results in the degradation of its associated partner, UVRAG, and reduction in levels of cellular phosphatidylinositol 3-phosphate.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1098/rsob.160255

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Targeted degradation of GFP-VPS34 also led to the degradation of endogenous UVRAG, a protein which forms a stable complex with VPS34.

    “Excitingly, targeted degradation of GFP-VPS34 also led to the degradation of endogenous UVRAG, a protein which forms a stable complex with VPS34 [18].”

    From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [18]

  • AdPROM combines the endogenous CUL2 CRL machinery with high-affinity polypeptide binders for target protein recognition.

    “Recent data from our own laboratory described a novel and efficient proteolytic system that combines the endogenous cullin 2 (CUL2) CRL machinery, with high-affinity polypeptide binders for target protein recognition [18, 19].”

    From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [18]

  • AdPROM can induce degradation of endogenous GFP-tagged PAWS1 and VPS34 using nanobodies recognizing GFP fused with VHL.

    “Alternatively, for POIs for which the binding nanobodies/monobodies do not yet exist, we generated GFP-tagged knockin POIs through CRISPR/Cas9 gene editing technology, and utilized nanobodies recognizing GFP fused with VHL to induce degradation of endogenous GFP-tagged PAWS1 and VPS34 [18].”

    From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [18]

  • Degradation of VPS34 by AdPROM resulted in reduction in levels of endosomal phosphatidylinositol (3,4,5)-trisphosphate.

    “As expected, the degradation of VPS34 by AdPROM resulted in reduction in levels of endosomal phosphatidylinositol (3,4,5)-trisphosphate [18].”

    From Advances in targeted degradation of endogenous proteins (2019) · cites this paper as [18]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 39 · Cited by 91

Authors
Fulcher, L. J., Macartney, T., Bozatzi, P., Hornberger, A., Rojas-Fernandez, A., & Sapkota, G. P.
Affiliations
  • University of Dundee (GB)
  • Center for Interdisciplinary Studies on the Nervous System and Institute of Medicine, Universidad Austral de Chile, Valdivia, Chile
Corresponding author
Sapkota, Gopal P.
Venue
Open Biology
Published
2016-10
Volume
6
Issue
10
Pages
160255
ISSN
2046-2441 (ISSN-L)
OpenAlex
W2544450870
Cited by
91
References
39
Citations by year
2026: 3 · 2025: 13 · 2024: 12 · 2023: 10 · 2022: 5 · 2021: 10 · 2020: 16 · 2019: 7 · 2018: 5 · 2017: 10
FWCI
3.81
Type
journal article
Language
en
Open access
Locations
  • Open Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Medical Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords
targeted proteolysis, von Hippel-Lindau protein, protein degradation, anti-GFP nanobody, CRISPR/Cas9 knock-in, Vps34, UVRAG, phosphatidylinositol 3-phosphate, proteasome, tetracycline-inducible expression
MeSH terms
Humans, Recombinant Fusion Proteins, Protein Engineering, Tumor Suppressor Proteins, Cell Line, Tumor, Von Hippel-Lindau Tumor Suppressor Protein, Smad1 Protein, Gene Knock-In Techniques, HEK293 Cells, Class III Phosphatidylinositol 3-Kinases, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review